Lemaitre Vascular (LMAT) Gross Profit (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Gross Profit data on file, last reported at $48.4 million in Q1 2026.

• On a quarterly basis, Gross Profit rose 16.84% year-over-year to $48.4 million in Q1 2026; TTM through Mar 2026 was $185.5 million, a 19.18% increase from a year earlier, with the FY2025 full-year figure at $178.5 million, up 18.32% from the prior year.
• Gross Profit for Q1 2026 stood at $48.4 million, up from $46.2 million in the prior quarter.
• Over the last five years, Gross Profit for LMAT reached as high as $48.4 million in Q1 2026 and fell as low as $25.1 million in Q3 2022.
• Historically, Gross Profit has averaged $35.9 million across 5 years, with a median of $36.7 million in 2024.
• Across the five-year window, Gross Profit climbed 0.38% in 2022 and rose 27.68% in 2023, its largest moves.
• Year by year, Gross Profit stood at $26.1 million in 2022, then advanced by 27.68% to $33.3 million in 2023, then grew by 16.01% to $38.6 million in 2024, then rose by 19.69% to $46.2 million in 2025, then grew by 4.78% to $48.4 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $48.4 million in Q1 2026, $46.2 million in Q4 2025, and $46.0 million in Q3 2025.